Transcriptome analysis reveals a ribosome constituents disorder involved in the RPL5 downregulated zebrafish model of Diamond-Blackfan anemia by Yang Wan et al.
RESEARCH ARTICLE Open Access
Transcriptome analysis reveals a ribosome
constituents disorder involved in the RPL5
downregulated zebrafish model of
Diamond-Blackfan anemia
Yang Wan1†, Qian Zhang2†, Zhaojun Zhang2, Binfeng Song3, Xiaomin Wang1, Yingchi Zhang1, Qiong Jia3,
Tao Cheng1, Xiaofan Zhu1, Anskar Yu-Hung Leung4, Weiping Yuan1*, Haibo Jia3* and Xiangdong Fang2*
Abstract
Background: Diamond–Blackfan anemia (DBA) was the first ribosomopathy associated with mutations in ribosome
protein (RP) genes. The clinical phenotypes of DBA include failure of erythropoiesis, congenital anomalies and
cancer predisposition. Mutations in RPL5 are reported in approximately 9 ~ 21 % of DBA patients, which represents
the most common pathological condition related to a large-subunit ribosomal protein. However, it remains unclear
how RPL5 downregulation results in severe phenotypes of this disease.
Results: In this study, we generated a zebrafish model of DBA with RPL5 morphants and implemented high-
throughput RNA-seq and ncRNA-seq to identify key genes, lncRNAs, and miRNAs during zebrafish development
and hematopoiesis. We demonstrated that RPL5 is required for both primitive and definitive hematopoiesis
processes. By comparing with other DBA zebrafish models and processing functional coupling network, we
identified some common regulated genes, lncRNAs and miRNAs, that might play important roles in development
and hematopoiesis.
Conclusions: Ribosome biogenesis and translation process were affected more in RPL5 MO than in other RP MOs.
Both P53 dependent (for example, cell cycle pathway) and independent pathways (such as Aminoacyl-tRNA
biosynthesis pathway) play important roles in DBA pathology. Our results therefore provide a comprehensive basis
for the study of molecular pathogenesis of RPL5-mediated DBA and other ribosomopathies.
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Background
Ribosomopathy is defined as a collection of diseases
caused by impaired ribosome biogenesis and function.
The clinical phenotypes often consist of bone marrow
failure and/or craniofacial or other skeletal defects [1].
Diamond-Blackfan anemia (DBA) (MIM 105650) was
the first ribosomopathy to be associated with genetic
mutations in ribosomal proteins when a mutation in
ribosomal protein S19 (RPS19) was first reported in
1999 [2]. It is also known as a rare inherited bone mar-
row failure syndromes (IBMFS) characterized by the fail-
ure of erythropoiesis with normal platelet and myeloid
lineages. The disease symptoms usually present within
the first year of life. Various associated physical malfor-
mation are observed in 30–50 % of DBA cases [3], and
cancer predisposition has been reported by cohort stud-
ies [4]. Corticosteroids, transfusion therapy and stem cell
transplantation are the mainstay of treatment [5]. Since
the initial identification of RPS19, approximately 50–
60 % of DBA patients have been found to have muta-
tions or deletions in genes encoding ribosomal protein
(RP) of both the small and large subunits, including
RPS24, RPS17, RPL35A, RPL5, RPL11, RPS7, RPS10,
RPS26, RPL26 and RPS29 [6, 7].
Ribosomal protein L5 (RPL5) is part of the 60S riboso-
mal subunit and is localized in both the cytoplasm and
nucleus of eukaryotic cells. Acting as a nucleocytoplas-
mic shuttle protein, it plays an important role in 5S
rRNA intracellular transport during assembly of the
large ribosomal subunit [8]. Mutations in RPL5 (MIM
603634) have been reported in approximately 5–10 % of
DBA patients [6]. Clinical data have shown that muta-
tions in RPL5 are associated with multiple physical ab-
normalities in DBA, and this was the first ribosomal
protein gene to be associated with cleft lip and/or cleft
palate abnormalities in DBA patients [9]. RPL5-mutated
induced pluripotent stem cells from DBA patients exhib-
ited defective 60S ribosomal subunit assembly, accumula-
tion of 12S pre-rRNA, and impaired erythropoiesis [10].
The pathogenesis of DBA and how ribosomal defects
produce a unique but diverse constellation of DBA abnor-
malities are still not fully understood. While it appears
that in the conditions of RP haploinsufficiency caused by
mutation of RP genes, RPL5, RPL11 and 5S rRNA bind to
human double minute (HDM2), which regulates the
proteasome-dependent degradation of P53 [11]. The
abnormal activation of p53 pathway may result in acceler-
ated apoptosis [12]. However, in many studies, both P53-
dependent and P53-independent pathways have been
confirmed to play a role in DBA pathogenesis [13–15].
In addition to mechanisms of gene regulation, functional
studies of microRNAs (miRNAs) (19 ~ 24-nucleotide non-
coding single-stranded RNA) and long noncoding RNAs
(lncRNAs) (exceed 200 nucleotides non-coding single-
stranded RNA) during development and hematopoiesis
were reported [16, 17]. For example, miR-145 and
miR-146a were identified as mediators of the 5q–
syndrome phenotype (another ribosomopathy that
primarily affects erythropoiesis) [18]. Several studies
have indicated that lncRNAs may have spatial and
temporal expression with potentially important roles
during development and differentiation in zebrafish
[19–21]. Some lncRNAs that are dynamically
expressed during erythropoiesis are targeted by key
erythroid transcription factors GATA binding protein
1 (GATA1), T-cell acute lymphocytic leukemia 1
(TALI), or Kruppel-like factor 1 (KLF1) [22]. How-
ever, the majority of lncRNAs remain uncharacter-
ized, and lncRNAs involved in erythropoiesis are just
beginning to be defined.
In this study, we generated zebrafish RPL5 morphants
and characterized the deregulated mRNAs, ncRNAs and
molecular regulatory networks in RPL5-deficient zebra-
fish embryos in comparison with controls using high-
throughput RNA-seq and ncRNA-seq techniques. The
RPL5-targeted central nodes of the mRNA regulatory
network that we constructed will help to better under-
stand the pathogenesis of DBA.
Results
Hematopoiesis and morphological abnormalities in RPL5
downregulation zebrafish
There are two isoforms of RPL5 (RPL5a and RPL5b),
and the ATG MO that we designed could inhibit both
isoforms in vivo. The effectiveness of the translation in-
hibition by RPL5 MO was confirmed by examining
green fluorescent fusion protein expression by fluores-
cence microscopy (Fig. 1a and b). Embryos injected with
control MO did not display any morphological changes,
while RPL5 deficiency in zebrafish at a low concentra-
tion of 0.25 ng/embryo resulted in hematopoietic and
developmental abnormalities resembling DBA, including
a ventrally bent tail, smaller head and a reduction in the
circulating blood cells as early as at 24hpf (Fig. 1c-e). At
48 hpf, hemoglobin-stained blood cells in the heart re-
gion were markedly decreased in RPL5 MO, which was
partially rescued when P53 MO was co-injected with
RPL5 MO, similar to our previous findings for RPS19
MO, RPL11 MO and RPS24 MO (Fig. 1f-k) [23–25].
The expression of the hemangioblast marker T-cell acute
lymphocytic leukemia 1 (scl) was significantly decrease-
d,as well as the primitive erythroid progenitor marker
gata1 and primitive myeloid progenitor marker Spi-1
proto-oncogene b (pu1) in RPL5 MO at 12 hpf. Moreover,
the expression of the definitive hematopoietic stem cell
markers v-myb avian myeloblastosis viral oncogene homo-
log (c-myb) and runt-related transcription factor 1(runx1)
was also markedly decreased in RPL5 MO at 48 hpf
Wan et al. BMC Medical Genomics  (2016) 9:13 Page 2 of 13
(Fig. 2). Furthermore, co-injection of RPL5 Mo and P53
MO could partially rescue the primitive, definitive
hematopoiesis defects caused by RPL5 MO alone (Fig. 2).
Differentially expressed genes in RPL5 MO
RNA-seq was used to identify and compare differential
expressed genes in RPL5 morpholino (RPL5 MO) and
control morpholino (Control) zebrafish embryos. Pair-
end deep sequencing was performed on mRNA-seq
libraries from these two samples. Using the TopHat
and Cufflinks packages, more than 13,000 annotated
genes were obtained, accounting for 83 % of the total
genes assembled in the Zv9 zebrafish genome. We iden-
tified 363 up-regulated genes and 1606 down-regulated
genes in RPL5 MO zebrafish (fold-change > 2, and
p-value < 0.05) (Fig. 3a). The expression levels of 5 of
these regulated genes (cirrhosis, autosomal recessive 1A
(cirh1a), NOC2-like nucleolar associated transcriptional
repressor (noc2l), ATP-binding cassette, sub-family E
(OABP), member 1(abce1), threonyl-tRNA synthetase
(tars), nucleolar protein 6 (nol6)) were examined using
RT-PCR, and the results confirmed that the expression
pattern showed a similarly trend between the RT-PCR
and RNA-seq results (Fig. 3b).
Compared with other DBA zebrafish models (such as
RPS19 MO zebrafish, RPS24 MO zebrafish, and RPL11
MO zebrafish), these differentially expressed genes
showed RPL5 MO had some general characters and little
specificity among those models [23–25]. 214 up-
regulated expressed genes in RPL5-deficient zebrafish
that were related to biological functions of translation
and proteolysis, showed the coordinated regulatory trend
in other DBA zebrafish models (Additional file 1: Table S1).
While 21 of the up-regulated genes in RPL5-deficient zeb-
rafish were down-regulated in other DBA zebrafish models
(Additional file 2: Table S2). The remaining 128 up-
regulated genes, enriched in the GO term of proteolysis,
showed no regularities in other DBA zebrafish models
(Fig. 3c). For down-regulated expressed genes in RPL5-
deficient zebrafish, 1205 out of them showed coordinated
regulatory trends when compared with other models
(Additional file 3: Table S3). Based on GO annotation, these
genes were found enriched in GO terms of regulation of
transcription, RNA/DNA metabolic process, organs and
systems development, cell cycle, and so on. While 168 out
of down-regulated genes in RPL5 MO, mainly related to
translation process, such as ribosome biogenesis, rRNA
processing, amino acid activation, and tRNA aminoacyla-
tion, had only slightly up-regulated expression in other
models (Additional file 4: Table S4). There were still 233
genes with no regular expression trend in these DBA zebra-
fish models and were enriched in biological functions
of RNA processing, regulation of cell development,
and translation (Fig. 3d). It is noteworthy that a portion of
significantly down-regulated genes was enriched in GO
annotation of hematopoietic development, such as dys-
keratosis congenita 1 (dkc1), CXXC finger protein 1b
(cxxc1), WD repeat domain 43 (wdr43), heat shock pro-
tein 9 (hspa9), ribosomal protein L22-like 1 (rpl22l1),
prostaglandin-endoperoxide synthase 2a (ptgs2a) and
odd-skipped related transcription factor 1 (osr1).
Genome-wide functional coupling network in RPL5 MO
To understand the interactive relationships among
deregulated genes and identify key factors in the abnormal
transcriptome of RPL5-deficient zebrafish, we input these
genes into the Funcoup framework (http://funcoup.sbc.
su.se/search/) to infer genome-wide functional couplings.
The network was generated using 1-expansion-depth and
grouped nodes for the ribosomal pathway (Fig. 3f). We
Fig. 1 Hemoglobin staining of embryos injected with RPL5 MO and
the effectiveness of RPL5 MO. a-b Embryos co-injected with 25 ng
RPL5:egfp DNA and 0.25 ng control MO produced green fluorescent
protein (a), and the expression of the green fluorescent fusion protein
was inhibited by co-injection with 0.25 ng RPL5 MO (b). c-e The
different phenotype and its ratio of embryos injected with 0.25 ng RPL5
MO f-k The O-staining results revealed a drastic reduction in the number
of hemoglobin-stained blood cells when RPL5 was knocked down (f and
i show the control; g and j show the RPL5 knockdown), and this was
partially rescued by coinjection with P53 MO (h and k). a, b, c, d, e,i, j
and k show the lateral view; f, g, and h show the ventral view
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found that RPL5a, which was significantly down-regulated
in our data, was functionally coupled with many other
ribosomal proteins such as RPS7, RPL9, RPS13, and
RPS27, although most of them were not detected by sig-
nificant expressional changes. More interestingly, these
ribosomal targets were also functionally coupled with
regulatory genes detected in other DBA zebrafish models.
Additionally, cirh1a, N-acetyltransferase 10 (nat10), noc2l,
dkc1, abce1, tars, polymerase (RNA) I polypeptide B
(polr1b), activator of heat shock protein ATPase homolog
1a (ahsa1), PWP2 periodic tryptophan protein homolog
(pwp2h), programmed cell death 11 (pdcd11), nucleolar
protein 6 (nol6), and apoptosis antagonizing transcription
factor (aatf) were found as central nodes in this network
(connectivity > 60), which were not overlapped well with
that of networks constructed by regulatory transcriptome
of other RP MOs. Based on the literature, many of these
genes are associated with the hematopoietic system, ribo-
some biogenesis and development process [26, 27].
Deregulated molecular signaling pathways in the RPL5-
deficient transcriptome
363 up-regulated genes and 1606 down-regulated genes
were mapped to the KEGG pathway database (http://
www.genome.jp/kegg/). Down-regulated genes in RPL5-
deficient zebrafish were also enriched in several import-
ant pathways (Table 1). Spliceosome pathway was
enriched by down-regulated genes mainly participating
in synthesis of the small nuclear RNAs (snRNA) named
U1, U2, U4, U5, and U6, which made up the major
spliceosome. Down-regulated genes were also involved
in the 4 phases of cell cycle (G1, S, G2, and M), espe-
cially DNA replication process in S phase. Another
enriched pathway was Aminoacyl-tRNA biosynthesis
pathway,which delivers the amino acid to the ribosome
for incorporation into the polypeptide chain that is being
produced. RPL5-deficient zebrafish showed defects
when tRNA was charged to L-Glutamine, L-Alanine,
L-Threonine, L-Cysteine, L-Methionine, L-Isoleucine,
Fig. 2 RPL5 is required for both primitive hematopoiesis and definitive hematopoiesis, which are partially mediated the by P53 pathway in
zebrafish. a-c The expression of scl was significantly decreased in RPL5 MO zebrafish and was partly rescued in RPL5 and P53 double MO
zebrafish at 12 hpf. d-i The expression of gata1 and pu1 was significantly decreased in RPL5 MO zebrafish and was partly rescued in RPL5 and
P53 double MO zebrafish at 12 hpf. j-o The expression of c-myb and runx1 was significantly decreased in RPL5 MO zebrafish and was partly
rescued in RPL5 and P53 double MO zebrafish at 48 hpf
Wan et al. BMC Medical Genomics  (2016) 9:13 Page 4 of 13
Fig. 3 Characterization of RPL5-deficient zebrafish embryos transcriptome and identification of differentially expressed genes. a Transcriptome
analysis identified 280 genes specifically expressed in RPL5 MO, 289 genes specifically expressed in Control, and 12916 commonly expressed
genes. In the commonly expressed genes, 363 significantly up-regulated genes and 1606 significantly down-regulated genes in the RPL5 MO
were detected using Cuffdiff (fold-change > 2 and p-value < 0.05). Venn diagram summarizes the number of differentially expressed genes, shared
and distinct genes expressed in RPL5 MO and Control. b Representative experimental validation of the regulated genes by Real-time PCR analysis.
Gene expression was represented as mean ± SD and Two-way ANOVA was performed for comparison between Control and RPL5-deficient zebrafish
embryos (**P < 0.001, *P < 0.01, n = 3). Gene expression in Control samples was normalized to 1. c-d The expression patterns of up-regulated genes (c)
and down-regulated genes (d), which was detected due to RPL5-deficiency, in other zebrafish models were showed by heatmaps. The corresponding
GO enrichment analysis for genes in coordinated regulatory trend, genes in opposite regulatory trend, and genes with no regularities compared with
other DBA zebrafish models was performed by DAVID tool. e Differentially expressed RP genes were detected in each DBA zebrafish model, which
was separately compared with Control to filter the differentially expressed RP genes with threshold of fold-change > 2 and p-value < 0.05. f Network
analysis of differential expressed genes based on FunCoup web source. The yellow diamond represents the significantly differential expressed gene in
RPL5-deficient zebrafish embryos (FPKM > 1, fold-change > 2, FDR < 0.05). Other nodes are connected with our query genes by 1-expansion-depth. All
the lines represent direct correlation of nodes
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L-Phenylalanine, and L-Tyrosine. Besides, pathways of
notch signaling, base excision repair, lysine degradation,
RNA degradation, pyrimidine metabolism, and selenoamino
acid metabolism were also enriched by down-regulated
genes. Up-regulated genes were mapped preferentially to
pathways associated with ribosome, and down-regulated
genes were enriched in pathways of spliceosome, cell cycle
and so on. (Table 1). We also compared the differentially
expressed RP genes in different DBA zebrafish models.
There were altogether 9 RP genes, expression of which was
significantly changed in RPL5 MO. While rare RP genes
were affected by RPS19, RPL11 or RPS24 knockdown
(Fig. 3e). Apparently, RPL5 knockdown made more influ-
ences on the expression of RP genes compared with other
DBA zebrafish models.
Characteristic lncRNome expression patterns of RPL5 MO
zebrafish and genes correlated with differentially
expressed lncRNAs
To determine the effects on global lncRNA transcription
profile due to ribosomopathies, we analyzed the
lncRNomes of DBA zebrafish models and the Control.
Using coding prediction and ORF (open reading frame)
identification, we found that 2028 potential lncRNAs were
expressed in these zebrafish samples at 48 hpf (Fig. 4a). By
unsupervised clustering of expression of all expressed
lncRNAs, we found that compared with the Control, the
majority of lncRNAs had lower expression in DBA zebra-
fish models. The expression pattern of genome-wide
lncRNAs of RPL5-deficient zebrafish seemed more spe-
cific for our previous DBA zebrafish models (RPS19
MO,RPL11 MO and RPS24 MO) that are all clustered to-
gether except for the RPL5 MO in this study (Fig. 4b).
Next, we identified the differentially expressed lncRNAs
between DBA zebrafish models and the Control (Fig. 4c).
Compared with genes, there were less commonly regu-
lated lncRNAs between diverse DBA zebrafish models.
We found only 7 commonly up-regulated lncRNAs and 8
down-regulated lncRNAs (fold-change > 2, p-value < 0.05).
In addition, we found that 8 lncRNAs were specifically
expressed in the Control sample and 24 lncRNAs were
specifically in DBA zebrafish models respectively.
Since lncRNAs have been demonstrated to be involved
in the transcriptional regulation, we explored the effects
of the differentially expressed lncRNAs on the expres-
sion of genes in DBA zebrafish models. We analyzed the
correlation between the expression of each lncRNA and
expressed gene. Interestingly, we found that a set of
commonly regulated lncRNAs (some were marked by ar-
rows in Fig. 4d), was significantly associated with more
than 3000 genes across the whole genome (Additional
file 5: Table S5). Using an absolute correlation coefficient
cutoff of greater than 0.8, we found a set of highly corre-
lated genes (Fig. 4d). These genes were enriched in GO
terms of structural constituent of ribosome, ribonucleo-
protein complex and so on (Fig. 4e).
MiRNAs involved in hematopoiesis and developmental
process in RPL5-deficient zebrafish
To understand the observed changes in the miRNome and
their biological functions in RPL5-deficient zebrafish em-
bryos, we compared the miRNA expression profiles in
RPL5 MO and the control animals. 6 of these regulated
miRNAs were confirmed by RT-PCR analysis, and the
ncRNA-seq results were validated using specific PCR for
results with significant differences (p-value < 0.01) between
RPL5-deficient zebrafish embryos and Control (Fig. 5b).
Using the DEGseq package, we identified 24 up-
regulated miRNAs, 20 down-regulated miRNAs and 14
RPL5-deficient specific miRNAs in zebrafish (fold-change >
1.5, p-value < 0.05). As previously reported, some of the
specifically expressed miRNAs in RPL5 MO (such as Dre-
mir-142a-3p, Dre-miR-34b and Dre-miR-15a*) and some
miRNAs with two-fold higher expression (such as Dre-
miR-150, Dre-miR-223 and Dre-miR-155) are involved in
the development and function of the hematological system
and most of the above-listed miRNAs participate in
normal hematologic functions by regulating the expres-
sion of c-myb [28–31]. Compared with other DBA zeb-
rafish models, regulatory miRNome of RPL5-deficient
zebrafish was more similar to that of RPS19 model
than RPS24 model (Fig. 5a). Interesting, there was 5
miRNAs (dre-miR-125c, dre-miR-140*, dre-miR-2191,
dre-miR-30b, dre-miR-459*) showing a coordinated regu-
latory trend among these DBA zebrafish models.
To determine the influences of regulated miRNAs on
gene expression, we used the MicroCosm Targets data-
base (http://www.ebi.ac.uk/enright-srv/microcosm/htdocs/
targets/v5/) to predict the potential targets for significantly
differential expressed miRNAs. We obtained 8799 target
genes for up-regulated expressed miRNAs and 7760 target
genes for down-regulated expressed miRNAs in RPL5-
deficient zebrafish. Then, we analyzed these target genes
Table 1 Pathways enriched by regulated genes (fold-change >
2 and p-value < 0.05) in RPL5 MO
Expression Pattern KEGG Pathway Count P-Value
Up-regulated Ribosome 10 1.90E-05
Down-regulated Spliceosome 25 2.80E-07
Down-regulated Cell cycle 26 4.00E-07
Down-regulated DNA replication 10 4.40E-04
Down-regulated Aminoacyl-tRNA biosynthesis 9 1.70E-03
Down-regulated Notch signaling pathway 11 2.20E-03
Down-regulated Base excision repair 7 1.80E-02
Down-regulated Lysine degradation 8 1.90E-02
Down-regulated RNA degradation 9 3.00E-02
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through comparison with our RNA-seq results. Because
the canonical miRNA regulation model suggests that miR-
NAs repress the expression of their downstream target
genes [32], we overlapped down-regulated genes with the
predicted targets of up-regulated miRNAs and overlapped
up-regulated genes with the predicted targets of down-
regulated miRNAs. As a result, we identified 73 signifi-
cantly up-regulated genes and 405 significantly down-
regulated genes as potential targets of regulated miRNAs
in RPL5-deficient zebrafish (Fig. 5c-d). GO analysis by
DAVID showed that enriched GO categories for the
down-regulated targets were primarily associated with
regulation of transcription, nerve system development,
RNA metabolic process, and cell development.
Discussion
RPL5 is required for both primitive and definitive
hematopoiesis
Hematopoiesis is a dynamic process consisted of primitive
and definitive hematopoiesis based on the type of blood
cells generated. Numerous transcription factors are in-
volved in the complex regulation of each stage. In zebra-
fish, the primitive hematopoiesis starts at ∼ 11 h post
fertilization (hpf) in the lateral plate mesoderm (LPM)
during somitogenesis [33]. In our RPL5 MO at 12 hpf,
primitive hematopoietic stem cell markers and the
hemangioblast marker scl, which is especially critical for
the development of arteries where adult hematopoietic
stem cells emerge [34], was significantly decreased.
Fig. 4 Identification of lncRNAs expressed in DBA zebrafish models. a Workflow for lncRNAs discovery. Details are described in “Methods”. b
Unsupervised clustering of expression of predicted lncRNAs for diverse DBA zebrafish models and Control model. c Number of differentially
expressed lncRNAs in different DBA zebrafish models compared with Control model, which was detected by R package DEGseq with threshold of
fold-change > 2 and p-value < 0.05. d Correlation heatmap between the expression of lncRNAs and genes. Rows represent genes expressed in
one of these zebrafish models, and the columns represent differentially expressed lncRNAs. The correlations between the expression of differentially
expressed lncRNA and all genes are calculated by Pearson method. With the threshold of absolute correlation coefficient |R|≥ 0.8, the significantly
correlated gene-lncRNA couplings are colored by red or green. A red color indicates a positive correlation, whereas green bars represent a negative
correlation. e Top 10 of the GO terms enriched by genes correlated with more than half of total differentially expressed lncRNAs
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The primitive erythroid progenitor marker gata1 and
primitive myeloid progenitor marker pu1 two master
regulators with a cross-inhibitory relationship that
regulates the primitive erythroid and myeloid fates, were
also markedly decreased. These data suggest that primitive
hematopoiesis is affected by RPL5 downregulation.
The onset of definitive hematopoiesis is marked by
the specification of HSCs, which support hematopoiesis
throughout the life of a vertebrate. C-myb and runx1
have been used as the earliest markers of definitive
hematopoiesis due to their expression in the aorta-gonad-
mesonephros (AGM) during HSCs specification. In our
RPL5 MO at 48 hpf, the definitive hematopoietic stem cell
markers c-myb and runx1 displayed similarly decreased
expression pattern. Hemoglobin-stained blood cells in the
heart region at 48 hpf were also markedly decreased, simi-
lar to the Rps19 MO, Rpl11 MO and RPs24 MO pheno-
types that we previously observed (Fig. 1) [23–25].
Some of the significantly down-regulated genes in
RPL5 MO also play important roles in primitive and
definitive hematopoiesis. For instance, osr1 is required
for the development of hemangioblast [35]. Specific de-
pletion of cxxc1, which was identified as a commonly
down-regulated genes among the four DBA zebrafish
models, inhibited genomic cytosine methylation and
primitive hematopoiesis in zebrafish [36]. It has been
demonstrated that deficiency of dkc1 in zebrafish led to
reduced definitive hematopoiesis mediated by P53 [37].
Moreover, wdr43 was identified as certain subunits re-
quired for definitive hematopoiesis [38]. Loss of hspa9
in zebrafish recapitulated the ineffective hematopoiesis
of the myelodysplastic syndromes [39].
In addition, many screened miRNAs were hematopoietic-
specific, especially dre-miR-142a-3p, which can result in
the loss of hematopoiesis during embryonic development
in zebrafish [28]. Moreover, dre-miR-34b, dre-miR-15a*
and dre-miR-150, which were thought to target c-myb, were
significantly up-regulated.
Based on the RPL5 MO phenotypes, expression pat-
terns of key genes and our mRNA-seq and ncRNA-seq
Fig. 5 Differential expressed miRNAs and their potential targets in RPL5-deficient zebrafish embryos. a The heatmap shows expression pattern of
miRNAs, which were significantly regulated with fold-change > 1.5 and p-value < 0.05 in RPL5 MO, in all DBA zebrafish models. The red module
represents the up-regulated miRNA and the blue module represents the down-regulated miRNA. b Representative experimental validation of the
regulated miRNAs by Real-time PCR analysis. miRNAs expression was represented as mean ± SD and Two-way ANOVA was performed for comparison
between Control and RPL5-deficient zebrafish embryos (**P < 0.001, *P < 0.01, n = 3). miRNAs expression in Control samples was normalized to 1. c-d
Overview of the regulatory networks containing differentially expressed miRNAs and their candidate mRNA targets in RPL5-deficient zebrafish embryos.
Red/green nodes denote up/down-regulated miRNAs, and pink/yellow nodes denote their potential up/down-regulated mRNA targets. Edges denote
the regulatory relationships between miRNAs and their predicted mRNA targets
Wan et al. BMC Medical Genomics  (2016) 9:13 Page 8 of 13
results, we believe that RPL5 is closely related to both
primitive hematopoiesis and definitive hematopoiesis.
Ribosome biogenesis were affected more in RPL5 MO
than in other RP MOs
Haploinsufficiency of RPs in DBA leads to not only pure
red cell aplasia but also developmental defects [3]. Not-
ably, mutation in RPL5 had a higher rate of malforma-
tion and was associated with a more severe phenotype
than mutations in RPS19 [9]. In zebrafish, knockdown of
ribosomal proteins leads to hypoplasia of the yolk sac
extension and gross morphological defects in the head
region [40]. Our RPL5 MO (0.25 ng/embryo) results
showed a more severe defective phenotype, when com-
pared with our previous RPL19 MO (2 ng/embryo),
RPL11 MO (0.5 ng/embryo), RPS24 MO (0.5 ng/embryo)
results, such as the severe curly tail morphology at 24 hpf
and almost invisible expression of hemangioblast marker
gene scl primitive erythroid progenitor marker gata1 and
myeloid progenitor marker pu1 at 12 hpf (not shown).
Working as a nucleocytoplasmic shuttle protein RPL5
plays a central role during the process of ribosomal as-
sembly. In this study, using mRNA-seq analysis, we
found about 2/3 of total differentially expressed genes in
RPL5 MO zebrafish had a concordant variation tendency
in expression level with other DBA zebrafish models.
These genes were related to functions of translation,
regulation of transcription and so on. While the
remaining genes (~1/3 of total differential expressed
genes in RPL5 MO), which were showing specific ex-
pressional changes compared with other DBA zebrafish
models, played important roles in proteolysis, ribosome
biogenesis and ribonucleoprotein complex biogenesis.
Interestingly, the up-regulation of ribosome pathway
that was detected by pathway enrichment analysis in
RPL5 MO, was not found in other DBA zebrafish models.
This apparent acceleration of ribosomal biogenesis pro-
cesses in RPL5 MO zebrafish may be caused by the feed-
back adjustments of RPL5 downregulation, but less severe
in other DBA zebrafish models. Furthermore, comparing
the differentially expressed ribosomal proteins in various
DBA zebrafish models, it seems that RPL5 knockdown af-
fects more the expression of ribosomal proteins. Our re-
sult confirmed the vital position of RPL5 in ribosome
biogenesis and related biological process. It also provided
a transcriptomic research basis to explain the special and
more severe clinical manifestation of RPL5 mutated DBA
patients in comparison with other DBA patients.
Interestingly, the genes correlated with more than half
of the differentially expressed lncRNAs were also enriched
in GO terms of structural constituent of ribosome and ri-
bonucleoprotein complex. It implicates that RPL5 may
have an important role in ribosome biogenesis by regulat-
ing some lncRNAs.
Both P53 dependent and independent pathways such as
Aminoacyl-tRNA biosynthesis pathway play important
roles in DBA pathology
The role of P53 pathway played in the pathogenesis of
DBA has been clearly demonstrated while the specific
regulatory mechanism is still largely unknown. In our
current study, the co-injection of P53 MO could par-
tially rescue the morphological and hematopoiesis de-
fects caused by RPL5 MO. From the transcriptome
analysis, although the P53 signaling pathway was not
significantly enriched, some genes involved in this path-
way were detected significantly regulated, such as p53,
mdm4, cyclin D2 a(ccnd2a), growth arrest and DNA-
damage-inducible, alpha a(gadd45aa), growth arrest and
DNA-damage-inducible, beta b (gadd45bb), topoisomer-
ase (DNA) II binding protein 1 (topbp1), guanine nu-
cleotide binding protein-like 3 (gnl3), (glycogen synthase
kinase 3 beta) gsk3b, cyclin D1 (ccnd1), and checkpoint
kinase 1 (chek1). Moreover, the direct miRNA targets of
P53, that were dre-miR-34a, dre-miR-145 and dre-miR-
15a [41], were differentially expressed in RPL5 MO
zebrafish when compared with the Control. P53 also is
known to play an important role in some down-regulated
genes enriched pathways that were mapped in RPL5-
deficient zebrafish. For example, P53 participates in the
cell cycle checkpoint control, such as G1/S checkpoint
regulation and G2/M DNA damage checkpoint regulation.
We found many cell cycle regulation genes were signifi-
cantly down-regulated in all four phases of the cell cycle.
Based on the transcriptome analysis, we also found some
important signaling pathways that were not correlated with
P53 directly or indirectly, such as aminoacyl-tRNA biosyn-
thesis pathway. Aminoacyl-tRNA biosynthesis is an import-
ant part of the translation process. In our data set, we
found that tRNA charged to L-Glutamine, L-Alanine,
L-Threonine, L-Cysteine, L-Methionine, L-Isoleucine,
L-Phenylalanine, and L-Tyrosine was inhibited by
down-regulated genes. These might have some correl-
ation with amino acid L-leucine. It was reported that
L-leucine, which increases translation via the mTOR
pathway and the phosphorylation of S6K and 4E-BP,
resulted in an improvement of anemia in zebrafish models
of both DBA and del(5q) syndrome [42]. Another study
showed that the administration of L-leucine significantly
improved anemia in RPS19-deficient mice, increased
the bone marrow cellularity, and alleviated stress
hematopoiesis [43]. Thus, we believe that dysfunction
in this pathway may lead to DBA symptoms via a re-
duction in leucine and the translation process.
Conclusion
Mutations in RPL5 are reported in approximately 9 ~ 21 %
of DBA patients, which represents the most common
condition related to a large-subunit ribosomal protein.
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Mutation in RPL5 is associated with a more severe clinical
phenotype [9].
In this study, we successfully generated zebrafish RPL5
morphants. Transcriptome deep sequencing was used to
characterize the transcriptome profile of RPL5 MO zeb-
rafish by comparing with other DBA zebrafish models
and found the common regulated genes, lncRNAs and
miRNAs for various kinds of DBA models. Our results
show that RPL5 downregulation in zebrafish results in
hematopoietic and developmental abnormalities that re-
semble human DBA. Both primitive hematopoiesis and
definitive hematopoiesis were disturbed in RPL5 MO.
Ribosome biogenesis and translation process were more
affected in RPL5 MO than in other RP MOs, which may
explain the clinical specialty of RPL5 mutated DBA pa-
tient. Moreover, both P53 dependent and independent
pathways such as Aminoacyl-tRNA biosynthesis pathway
play important roles in DBA pathology. Since almost all
of genes that we screened were conserved in humans,
future functional studies in mammalian and human cells




All of the studies using zebrafish were approved by the
Animal Care and Use Committee of Huazhong Univer-
sity of Science and Technology.
Zebrafish embryo maintenance, RPL5 morpholino (MO)
microinjection, and hemoglobin staining
Wild-type zebrafish (Danio rerio; AB type) were bred
and maintained under standard library conditions.
Zebrafish embryos were kept in a 28.5 °C incubator,
and the embryonic stages evaluated in this study have
been previously described [44, 45]. The RPL5 MO (5-
ACCCATTTTGTGATCGTTTGTTCTC-3), control MO
(5- ACCCGTTTCGTAATCGTCTGTGCTC-3) and P53
MO (5- GCGCCATTGCTTTGCAAGAATTG-3) were
obtained from Gene-Tools, LLC (Philomath, OR, USA).
Zebrafish embryos at the one-cell stage were injected with
the MOs using a microinjector (WPI SYS-PV830). Based
on our initial trials, 0.25 ng RPL5MO and control MO was
chosen as the optimal concentration. Injected embryos
were grown at 28.5 °C and observed under a microscope.
The effectiveness of translational inhibition by RPL5 MO
was tested in vivo using the RPL5:egfp green fluorescent fu-
sion protein under fluorescence microscopy. The O-
dianisidine (Sigma) staining protocols were performed as
previously described [23] [24] and images were collected
using an Olympus microscope with a digital camera
(OLYMPUS IX71) and imported into Adobe Photoshop
CS2 9.0.2 for orientation and figure preparation.
Total RNA isolation, library preparation, and sequencing
Immediately after harvesting, 40–50 pooled embryos
at 48 hpf from different experimental replicates were
snap-frozen in liquid nitrogen and stored at −80 °C.
Total RNA was extracted from pooled embryos using
Trizol reagent (Invitrogen) according to the manufac-
turer’s instructions. RNA concentrations were deter-
mined using a NanoDrop 2000 (Thermo Scientific).
The integrity of the RNA samples was checked using
1.2 % agarose gel electrophoresis, followed by removal
of residual genomic DNA with RNase-free DNase I
(Ambion).
Libraries of mRNA and miRNA were constructed
using the Illumina mRNA-Seq and ncRNA library prep-
aration kit according to the manufacturer’s instructions,
respectively. The concentration and size distribution of
the libraries were checked using an Agilent Bioanalyzer
DNA 2000 chip (Agilent Technologies), followed by se-
quencing on an Illumina Hiseq 2000 sequencing plat-
form. The RNA-Seq library was sequenced with 2 ×
100 bp in pair-end mode by 100-bp lengths, and the
ncRNA library was sequenced in single-end mode by 80-
bp lengths. A total of 37–40 million reads were collected
for RNA-Seq analysis and 3.8–13.5 million reads for
ncRNA analysis.
Mapping, annotation, and expression difference analysis
for mRNA-seq data
Reads were processed and aligned to the UCSC zebrafish
reference genome (build Zv9/danRer7, Jul. 2010) using
TopHat (version 1.3.3) [46]. TopHat incorporates the
Bowtie v0.12.7 algorithm to perform alignments. In brief,
TopHat initially removes a portion of reads based on the
quality of information accompanying each read and
maps qualified reads to the reference genome. The refer-
ence index was built using Bowtie with a fasta file for
the entire genome of zebrafish, which was downloaded
from UCSC (http://genome.ucsc.edu/). Parameters were
set by default, but the number of threads to align reads
was set at 6. TopHat aligned read files were then entered
into the Cufflinks (version 1.2.1) software for further
analyses, including transcript assembly, abundance esti-
mation, and differential expression and regulation testing
in RNA-Seq samples [47]. To calculate the gene expres-
sion intensity, read counts were normalized to the num-
ber of fragments per kilobase of transcript per million
mapped reads (FPKM) according to the gene length and
total mapped reads [48]. Confidence intervals for esti-
mates of FPKM were calculated using a Bayesian inference
method [49]. Cuffdiff then performed the differential
expression tests at the level of transcripts, primary
transcripts and genes [49]. Differential expressed genes
were characterized according to the criterion of a fold-
change > 2 and p-value < 0.05.
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lncRNome identification and characterization
Cufflinks script was used to determine whether the de-
tected transcripts were annotated by Refseq genes of zebra-
fish genome (build Zv9/danRer7, Jul. 2010). All of the
annotated transcripts were eliminated, and the non-
annotated transcripts were used for downstream analysis.
Next, transcripts with a length more than 200 bp were
filtered out for coding potential prediction analysis
using Coding Potential Calculator software (CPC, http://
cpc.cbi.pku.edu.cn/), which assessed the protein-coding po-
tential of a transcript based on six biologically meaningful
sequence features [50]. Transcript whose predicting result
from CPC was ‘noncoding’ was considered as noncoding
RNA of high potential and kept for the next step analysis
[19]. Further, the selected transcripts translated in all 6
reading frames into amino acid sequences were matched
to Pfam database by PfamScan, which was used to identify
transcripts containing protein-coding domains [51]. For
PfamScan, a cutoff e-value of 0.01 was used. Then the
remaining transcripts were analyzed by GETORF, which
was widely used to find and extract open reading frames
(ORFs) (http://emboss.sourceforge.net/apps/cvs/emboss/
apps/getorf.html) [52]. Transcripts containing ORFs of
more than 300 nucleotides were removed, and the
remaining transcripts were classified as putative lncRNAs.
Mapping, annotation, and expression difference analysis
for miRNA-seq data
First, FASTX-Toolkit clipper was used to remove se-
quencing adapters. Then, we converted the fastq file to a
tab-delimited file, which held only the unique sequence
read (tag) and the corresponding number of copies.
After data preprocessing, we uploaded this file to DSAP
(http://dsap.cgu.edu.tw) for the clustering of tags and
classification of non-coding small RNAs and miRNAs
based on sequencing homology searches against the Rfam
and miRBase databases, respectively [53]. The differen-
tially expressed miRNAs were detected with the R package
DEGseq using the output data from DSAP. The threshold
for filtering out the differentially expressed miRNAs is
fold-change > 1.5 and p-value < 0.05.
Gene ontology analysis and network construction
DAVID tool (https://david.ncifcrf.gov) was used for identi-
fying enriched biological themes and discovering enriched
canonical pathways in KEGG database [54, 55]. Enriched
GO terms with Gene-Count > 5 and p-value < 0.05 were
accepted for further discussion. We then constructed the
functional coupling network for differentially expressed
genes using FunCoup v3.0 (http://funcoup.sbc.su.se/
search/), which provided an unspecific form of association
encompassing direct physical interactions but also more
general types of direct or indirect interactions such as
regulatory interactions or participation the same process
or pathway [56]. In addition, the linkages between genes
and miRNAs were constructed based on the targeting in-
formation from the MicroCosm Target database (http://
www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5/).
Visualization of the regulatory relationship is implemented
by Cytoscape software [57]. The importance of nodes in
the networks was measured based on their connectivity,
and the core molecules of the networks were considered
nodes that were connected with greater numbers of edges.
Quantitative Real-time PCR and Whole mount in situ
hybridization
Real-time PCR of mRNA and miRNA was performed
using SYBR Green PCR Master Mix (Fermentas,
Guangzhou, China) and the All-in-OneTM miRNA qPCR
Kit (GeneCopoeia, Maryland, USA), respectively, accord-
ing to the manufacturer’s instructions. The experiments
were repeated at least in triplicate. The primers for real-
time PCR are shown in Additional file 6: Table S6. The
digoxigenin-labeled antisense riboprobes were transcribed
from a linearized plasmid containing gata1, pu1, scl, c-
myb and runx1 using DIG RNA labeling Mix and T7 RNA
polymerase (Roche, USA) [37, 58]. Whole-mount in situ
hybridization was conducted as previously described [23].
Data access
Supporting data sets are available in the Gene Expres-
sion Omnibus, with the accession number GSE58347,
GSE54270, GSE51326, and GSE45699.
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change > 2 and p-value < 0.05) showed coordinated regulatory trend in
other DBA zebrafish models. (DOC 196 kb)
Additional file 2: Table S2. Up-regulated genes in RPL5 MO (fold-
change > 2 and p-value < 0.05) showed opposite regulatory trend in
other DBA zebrafish models. (DOC 39 kb)
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